Today: 20 March 2026
Unilever shares slip in early London trade — what investors watch before Feb 12 results
7 January 2026
1 min read

Unilever shares slip in early London trade — what investors watch before Feb 12 results

London, Jan 7, 2026, 08:55 GMT — Regular session

Unilever PLC shares fell 0.9% to 4,703.5 pence by 08:28 GMT, leaving them down about 2.5% since Jan. 2. The stock traded between 4,698 and 4,750 pence and is about 5% below its 52-week high of 4,930 pence. Share Prices

The move came as European shares paused after a string of record closes, with investors weighing U.S.-Venezuela headlines and a busy economic calendar. Oil prices fell after U.S. President Donald Trump said Washington had struck a deal to import $2 billion worth of Venezuelan crude, while Nestle slid after recalling some batches of infant nutrition products over possible contamination.

Investors have also been digesting Unilever’s post-ice-cream overhaul after the group split off its Magnum business in December. In the same month, Unilever said it would consolidate shares at an 8-for-9 ratio after completing the demerger.

“Our performance excluding Ice Cream showed good sequential improvement, with a step up in volume growth,” chief executive Fernando Fernandez said in Unilever’s October trading update. The company reiterated its full-year outlook for 3%-5% underlying sales growth — a measure that strips out currency swings and deal effects — and said it still expected €800 million of productivity savings. It forecast about €650 million of those savings by end-2025, with the remaining €150 million to come in 2026. Unilever

London’s FTSE 100 closed at a record high on Tuesday, rising 1.4% to 10,112.73 points, after AstraZeneca jumped on a strategic collaboration announcement and a weaker pound helped exporters. The benchmark has started 2026 strongly, with investors pricing in Bank of England rate cuts later this year.

But Unilever’s next update will need to show steady volume-led growth and clean execution after the ice cream separation, or investors may question how much of the recent sales momentum is coming from price rises rather than demand. A sharp swing in currencies or renewed cost inflation would also test margins in 2026.

Stock Market Today

  • Kessler Topaz Meltzer & Check Files Securities Fraud Class Action Against Soleno Therapeutics
    March 20, 2026, 1:23 PM EDT. Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) concerning purchases of SLNO stock between March 26 and November 4, 2025. The lawsuit alleges that Soleno made materially false statements and omissions about safety concerns in its Phase 3 clinical trial for diazoxide choline extended-release tablets used to treat hyperphagia linked to Prader-Willi syndrome. The firm claims the company concealed issues relating to excess fluid retention in trial participants. Investors have until May 5, 2026, to seek lead plaintiff status. The complaint is pending in the U.S. District Court for the Northern District of California under case number 3:26-cv-01979. Investors who suffered losses are urged to contact the law firm for legal options at no cost.
Maruti Suzuki share price today slides 3% after nearing 52-week high; Phillips 66 draws focus on UK Lindsey deal
Previous Story

Maruti Suzuki share price today slides 3% after nearing 52-week high; Phillips 66 draws focus on UK Lindsey deal

RELX share price rises in London after buyback update as investors eye Feb. 12 results
Next Story

RELX share price rises in London after buyback update as investors eye Feb. 12 results

Go toTop